[关键词]
[摘要]
中药凭借其独特的临床疗效逐步赢得国际市场认可，在这一进程中，质量控制体系的现代化转型成为制约其发展的核心命题。随着中药产业智能化升级的深入推进，近红外光谱技术（near infrared spectrum，NIRS）在中药生产和质量控制领域中迅速发展，正逐步成为推动中药产业技术革新的关键力量。通过对NIRS在中药领域的相关专利进行深入剖析，系统探讨了该技术在中药领域的技术演进路径与应用突破方向。研究主要从“专利概况-应用场景”2个维度来深度剖析，主要涵盖申请人分布、模型构建方法、应用范围（中药材、提取物、制剂）、地理分布和专利对比分析，详细阐述了NIRS技术在中药生产过程中的在线监测与质量控制方面的实际应用情况，为国内中药领域NIRS的实践应用提供坚实的科学支撑，进一步推动中药行业的产业升级与创新发展。
[Key word]
[Abstract]
With its unique clinical efficacy, traditional Chinese medicine (TCM) has gradually won recognition in the international market. In this process, the modern transformation of quality control system has become the core proposition that restricts its development. With the deepening of intelligent upgrading of TCM industry, near infrared spectrum (NIRS) has developed rapidly in the field of TCM production and quality control, and is gradually becoming a key force to promote technological innovation of TCM industry. In this study, the related patents of NIRS in the field of TCM were deeply analyzed, and the technological evolution path and application breakthrough direction of this technology in the field of TCM were systematically discussed. The research mainly analyzes in depth from the two dimensions of “patent overview-application scenarios”, mainly covering the distribution of applicants, model construction methods, application scope (Chinese herbal medicines, extracts, preparations), geographical distribution and patent comparative analysis, and expounds in detail the practical application of NIRS technology in online monitoring and quality control in the production process of TCM. Finally, according to the research results, the technical development bottleneck and breakthrough direction of NIRS in the field of TCM were comprehensively sorted out, aiming at providing solid scientific support for the practical application of NIRS in the field of TCM in China, and further promoting the industrial upgrading and innovative development of TCM industry.
[中图分类号]
R28
[基金项目]
国家中医药管理局科技司-浙江省中医药管理局共建科技计划项目（GZY-ZJ-KJ-24040）；浙江省药品监督管理与产业发展研究会项目（ZYH2024008，ZYH2024007）；浙江康恩贝制药股份有限公司中药材饮片事业部2024年创新创效项目（2024ZZCXCY01）
